Prediction: IonQ Faces Headwinds Amid Quantum Hype
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
When To Choose Robo Over Manual Investing 2026
Discover the best timing for robo versus manual investing in 2026. This intro outlines criteria, costs, and expected outcomes to guide your choice.
26,911 articles
Rate Cuts Table Outlook: 2 Stocks Under $30 Ready Now
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...
Peter Schiff: Trillion Capex Sparks AI Investment Debate
A trillion-dollar AI capex push by hyperscalers and chipmakers is fueling a fierce debate over whether the spending w...
Axcelis Corporate Controller Sells: Is ACLS Stock Worth It?
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
Crypto Finally Clarity Date Faces Senate Hurdles Ahead
The CLARITY Act moves to a July field hearing in New York, but final passage now hinges on seven Senate Democrats. An...
$900,000 Inherited 401(k): 10-Year Rule Update
A $900,000 inherited 401(k) faces the SECURE Act’s 10-year rule, with recent IRS guidance adding complexity for heirs...
Stock Market Live July 14: S&P 500 Rebounds on Inflation Data
U.S. stocks climbed on Tuesday as inflation cooled more than expected, helping the S&P 500 regain ground. Futures poi...
Zero Bitcoin: This Miner Sells Everything It Produces
A Singapore-based crypto miner reveals it has sold all mined Bitcoin to shore up liquidity for AI and high-performanc...
Claim Social Security at 62? Ramsey Advice Questioned
As funding gaps loom for Social Security, advice to claim at 62 faces renewed scrutiny. Analysts warn that early clai...
Why Investors Should Their Money in Gold: 10% Rule
A prominent market strategist says investors should their money in gold, proposing a 10% allocation to hedge inflatio...
Analysts See Disney Streaming Upside as Profit Surges
Disney reports a profitable quarter for its streaming arm, marking a profitability milestone that could spark upside ...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status